Alaunos Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,285 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page
25
Current page
2
SCHEDULE 13D/A File 005-79364

SCHEDULE 13D/A filing

Filing date
24 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
12 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
12 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
12 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B8 File 333-291002

424B8

Filing date
11 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-79364

SCHEDULE 13D/A filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
21 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
21 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
21 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-289748

S-3/A

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-79364

SCHEDULE 13D/A filing

Filing date
31 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-79364

SCHEDULE 13D filing

Filing date
30 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-79364

SCHEDULE 13G/A filing

Filing date
16 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-289748

S-3/A

Filing date
02 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289748

UPLOAD filing

Filing date
17 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-289748

S-3/A

Filing date
09 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-79364

SCHEDULE 13D/A filing

Filing date
05 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-79364

SCHEDULE 13G filing

Filing date
04 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289748

UPLOAD filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .